Researchers established a screening system to identify gut microbiome-derived metabolites that may regulate anti-tumor immunity in microsatellite-stable colorectal cancer by modulating the PD-1/SHP-2 signaling pathway. (Journal for ImmunoTherapy of Cancer)
Gut Microbial Metabolites Screened for Role in Modulating PD-1/SHP-2 Interaction in MSS CRC
The CRC Digest